U3O8$...0.00%|CCJ$...0.00%|OKLO$...0.00%|CEG$...0.00%|URA$...0.00%|URNM$...0.00%|NXE$...0.00%|U3O8$...0.00%|CCJ$...0.00%|OKLO$...0.00%|CEG$...0.00%|URA$...0.00%|URNM$...0.00%|NXE$...0.00%|
SECOND ATOMIC AGE

Nuclear Markets

Nuclear energy equities · Prices delayed 15 minutes

Stale
17 stocks ▲|27 stocks ▼|Market Closed

Derivatives

URANIUM-USD PerpetualQFEXPERP
$86.50-0.80% 24h
Funding Rate
+1.0000%
Mark Price$86.52
24/7 · No expiry · Source: QFEXTrade →

Click any stock to update the chart ↑

Powered by TradingView

Reactor Developers

Uranium Miners

Utilities & Operators

Nuclear Utilities

ETFs & Funds

Enrichment & Fuel

Services & Components

Prediction Markets

Kalshi & Polymarket · Real-money nuclear contracts

Upcoming Earnings

Next 30 days · Nuclear universe

0 companies

No earnings scheduled in the next 30 days.

Recent Results

Last 90 days · Beat / miss vs. consensus

17 reports
TickerReport DateEPS Est / ActStatus
UEC2026-06-16-$0.05Pending
UEC2026-06-09-$0.05-$0.11Miss
UEC2026-06-01-$0.05Pending
DNN2026-05-12-$0.02-$0.13Miss
OKLO2026-05-12-$0.20-$0.19Beat
CEG2026-05-11$2.59$2.74Beat
URG2026-05-08-$0.03-$0.07Miss
SMR2026-05-07-$0.13-$0.14Miss
VST2026-05-07$1.35$2.87Beat
URG2026-05-06-$0.03Pending
UUUU2026-05-06-$0.05-$0.04Beat
EXC2026-05-06$0.89$0.91In Line
NXE2026-05-05-$0.04-$0.24Miss
CCJ2026-05-05$0.37$0.30Miss
LEU2026-05-05$0.56$1.05Beat
BWXT2026-05-04$0.94$1.12Beat
NXE2026-04-30-$0.04Pending

AI Reaction Notes

UEC

UEC missed with $0 revenue and wider EPS loss, underscoring its pre-production uranium development stage.

DNN

DNN's Q1 2026 earnings miss, with wider EPS loss and lower revenue, signals higher costs impacting uranium project development.

OKLO

Oklo beat Q1 2026 EPS by $0.0066 with zero revenue, indicating disciplined pre-revenue nuclear development spend.

CEG

CEG beat Q1 2026 EPS/revenue estimates, underscoring strong nuclear operations and uranium demand upside.

URG

URG missed Q1'26 estimates as EPS widened to -0.07, signaling higher costs for uranium operations.

SMR

NuScale missed Q1 estimates with a wider loss and far lower revenue, raising SMR deployment concerns for uranium investors.

VST

Vistra's strong EPS beat highlights robust earnings power from its nuclear fleet, supporting uranium demand growth.

UUUU

UUUU beat Q1 2026 estimates, with revenue of $35.8B exceeding expectations on uranium sales strength.

EXC

EXC posted inline Q1 earnings with modest EPS/revenue beats, underscoring stable nuclear fleet output.

NXE

NXE posted a wider Q1 loss than expected but stayed pre-revenue, as typical for its development stage.

CCJ

CCJ missed Q1 EPS estimates despite a revenue beat, tempering optimism for uranium production growth.

LEU

LEU beat Q1 2026 EPS 1.05 vs 0.56, underscoring robust profitability in uranium enrichment.

BWXT

BWXT beat Q1 2026 EPS and revenue estimates, underscoring robust nuclear demand and execution.